Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

407
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
407
Relative Risk01:12

Relative Risk

2.0K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.0K
Framing Effects03:26

Framing Effects

7.9K
Information is everywhere and its presentation—such as how and when items are presented—can impact our perceptions and decisions surrounding the info. This broad concept umbrellas framing effects—influences that occur due to the way information is framed in its appearance, whether it’s purely the order or the specific wording of a message. Let’s take a look at numerous ways in which two versions of something can objectively say the same thing, yet we respond in...
7.9K
Hazard Ratio01:12

Hazard Ratio

561
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
561
Hazard Rate01:11

Hazard Rate

402
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
402
Odds Ratio01:09

Odds Ratio

1.7K
The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Audio Interview: Assessing the Effect of Vaccination and Prior SARS-CoV-2 Infection.

The New England journal of medicine·2022
Same author

Audio Interview: Covid-19: Where Are We Heading?

The New England journal of medicine·2022
Same author

Audio Interview: Developing New Covid-19 Vaccines.

The New England journal of medicine·2022
Same author

Audio Interview: Infectious Disease in Africa.

The New England journal of medicine·2022
Same author

Failing upwards: Genetics-based strategies to improve antibiotic discovery and efficacy in <i>Mycobacterium tuberculosis</i>.

Frontiers in cellular and infection microbiology·2022
Same author

Audio Interview: Assessing Bivalent Vaccines against Covid-19.

The New England journal of medicine·2022
Same journal

Sparganosis.

The New England journal of medicine·2026
Same journal

Caring for an Aging America - The Looming Crisis of the Long-Term-Care Workforce.

The New England journal of medicine·2026
Same journal

For Those Left Behind.

The New England journal of medicine·2026
Same journal

Colliding Forces - The Aging of the Baby Boom Generation and Contracting Nursing-Home Supply.

The New England journal of medicine·2026
Same journal

Mandated State-Level Surveillance of Assisted Reproductive Technology - An Emerging Threat in the United States.

The New England journal of medicine·2026
Same journal

Ebola at 50 - Lessons for Outbreak Response and Preparedness.

The New England journal of medicine·2026
See all related articles

Related Experiment Video

Updated: Jan 17, 2026

Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods
13:04

Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods

Published on: September 19, 2012

12.4K

Risk and Benefit

Eric J Rubin

    The New England Journal of Medicine
    |September 24, 2025
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    An R-Based Landscape Validation of a Competing Risk Model
    05:37

    An R-Based Landscape Validation of a Competing Risk Model

    Published on: September 16, 2022

    2.5K
    Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
    07:05

    Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents

    Published on: September 10, 2018

    6.4K

    Related Experiment Videos

    Last Updated: Jan 17, 2026

    Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods
    13:04

    Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods

    Published on: September 19, 2012

    12.4K
    An R-Based Landscape Validation of a Competing Risk Model
    05:37

    An R-Based Landscape Validation of a Competing Risk Model

    Published on: September 16, 2022

    2.5K
    Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
    07:05

    Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents

    Published on: September 10, 2018

    6.4K